[Monitoring clinical stages of testicular tumors using markers].
The authors evaluate a group of patients with a germinal testicular tumour treated at the urological clinic in Hradec Králové in 1975-1987. The group of 212 patients comprised 60 with seminomas, 152 with non-seminomas. Of these 152 138 men were examined for HCG and 84 for AFP. According to different diagnoses and the clinical stage the authors analyze in detail the assessed values of HCG and AFP. Both markers were on average elevated by 30 to 40%, only in patients with teratocarcinoma stage B 3 AFP is elevated in 100% of the men. The findings are consistent with data in the literature.